Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.
暂无分享,去创建一个
A. Garden | K. Ang | R. Weber | S. Lippman | J. Lee | E. Sturgis | K. Chao | Michelle D. Williams | J. J. Lee | B. Moeller | H. Macapinlac | D. Rosenthal | W. Morrison | D. Schwartz | L. Ginsberg | S. Frank | G. Chronowski | V. Rana | B. Cannon | M. Williams | D. Schwartz | M. Williams | K. Chao | Michelle D Williams
[1] Albert C. Koong,et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. , 2009, International journal of radiation oncology, biology, physics.
[2] A. Garden,et al. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Buatti,et al. Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report. , 2009, International journal of radiation oncology, biology, physics.
[4] Jens Overgaard,et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] C. Tsien,et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. Cmelak,et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.
[7] B. Têtu,et al. Prognostic Significance of Cyclooxygenase-2 Overexpression in Glottic Cancer , 2008, Clinical Cancer Research.
[8] L. Peters,et al. Clinical impact of, and prognostic stratification by, F‐18 FDG PET/CT in head and neck mucosal squamous cell carcinoma , 2007, Head & neck.
[9] Witold Zatonski,et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. , 2007, Journal of the National Cancer Institute.
[10] A. Garden,et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. , 2007, International journal of radiation oncology, biology, physics.
[11] H. Taubert,et al. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels. , 2006, International journal of radiation oncology, biology, physics.
[12] W. Mendenhall,et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] D. Rimm,et al. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Christopher U. Jones,et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.
[15] A. Garden,et al. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. , 2005, International journal of radiation oncology, biology, physics.
[16] I. Gich,et al. Comparison of the Radiation Therapy Oncology Group recursive partitioning classification and Union Internationale Contre le Cancer TNM classification for patients with head and neck carcinoma , 2005, Head & neck.
[17] Vincent Gregoire,et al. Is there any future in radiotherapy planning without the use of PET: unraveling the myth... , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] M. Leblanc,et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. , 2004, Archives of otolaryngology--head & neck surgery.
[19] Q. Wei,et al. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] G. Calais,et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] T. Reichert,et al. Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. , 2003, Oral oncology.
[22] Mohamed Allaoua,et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M N Maisey,et al. FDG–PET. A possible prognostic factor in head and neck cancer , 2002, British Journal of Cancer.
[24] J. Myles,et al. P53 and Ki‐67 as Outcome Predictors for Advanced Squamous Cell Cancers of the Head and Neck Treated With Chemoradiotherapy , 2001, The Laryngoscope.
[25] J. Cooper,et al. Validation of the RTOG recursive partitioning classification for head and neck tumors , 2001, Head & neck.
[26] K. Heimdal,et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study , 2000, The Lancet.
[27] B. Jeremic,et al. Hyperfractionated Radiation Therapy With or Without Concurrent Low-Dose Daily Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Prospective Randomized Trial , 2000 .
[28] R. Day,et al. Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival , 1998 .
[29] H. Minn,et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] J. Cooper,et al. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer , 1996, Cancer.